RELAY THERAPEUTICS INC (RLAY)
US75943R1023 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 152.36M | 143.74M | 151.80M | 280.10M | 447.60M | |||
| Marketable Securities | 687.25M | 606.35M | 847.10M | 678.00M | 230.40M | |||
| Receivables | N/A | 0.00 | 5.20M | 4.90M | 82.70M | |||
| Other Current Assets | 25.52M | 20.02M | 15.40M | 13.20M | 9.40M | |||
| Total Current Assets | 865.13M | 770.10M | 1.02B | 976.20M | 770.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 60.57M | 68.87M | 75.40M | 27.30M | 28.80M | |||
| Intangibles | 2.30M | 2.30M | 2.30M | 2.30M | N/A | |||
| Other Non-Current Assets | 2.12M | 2.71M | 2.60M | 2.60M | 900.00K | |||
| Total Non-Current Assets | 64.99M | 73.88M | 80.30M | 32.20M | 29.70M | |||
| TOTAL ASSETS | 930.12M | 843.98M | 1.10B | 1.01B | 799.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 38.74M | 19.06M | 25.40M | 15.20M | 7.10M | |||
| Accounts Payable | 6.87M | 9.21M | 10.60M | 8.30M | 6.40M | |||
| Other Current Liabilities | 1.36M | 2.00M | 27.70M | 800.00K | 200.00K | |||
| Total Current Liabilities | 46.97M | 30.27M | 63.70M | 24.30M | 13.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 44.29M | 61.71M | 85.80M | 86.30M | 22.90M | |||
| Total Non-Current Liabilities | 44.29M | 61.71M | 85.90M | 86.30M | 22.90M | |||
| TOTAL LIABILITIES | 91.25M | 91.98M | 149.60M | 110.60M | 36.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.66B | -1.40B | -1.06B | -768.10M | -404.20M | |||
| Additional Paid In Capital | 2.50B | 2.15B | 2.02B | 1.67B | 1.17B | |||
| Common Shares | 167.00K | 127.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 2.51M | -196.00K | -10.40M | -1.10M | 100.00K | |||
| Shares Outstanding | 166.89M | 127.46M | 121.10M | 108.20M | 89.90M | |||
| Tangible Book Value per Share | 5.01 | 5.88 | 7.83 | 8.28 | 8.49 | |||
| Total Shareholders' Equity | 838.86M | 752.00M | 950.20M | 897.80M | 763.30M | |||
| TOTAL LIABILITIES AND EQUITY | 930.12M | 843.98M | 1.10B | 1.01B | 799.80M | |||
| Statistics | ||||||||
| Current Ratio | 18.42 | 25.44 | 16.00 | 40.17 | 56.63 | |||
| Return On Assets (ROA) | -64.90% | -40.52% | -26.41% | -36.08% | -28.78% | |||
| Return On Equity (ROE) | -71.96% | -45.47% | -30.57% | -40.53% | -30.16% | |||
All data in USD , ROIC based on taxRate of 0.21